Sfoglia per AUTORE
COCO B
Collezione AOU Città della Salute di Torino

  

Items : 5

Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAA. in Alimentary pharmacology & therapeutics / Aliment Pharmacol Ther. 2025 Feb;61(3):538-549. doi: 10.1111/apt.18409. Epub 2024 Nov 21.
2025
AOU Città della Salute di Torino

Brunetto MR; Saracco GM; Perbellini R; Monico S; Cavallone D; Coco B; Troshina G; Damone F; Abate ML; Birolo G; Ricco G; Degasperi E; Colombatto P; Fariselli P; D'Ambrosio R; Caviglia GP; Lampertico P; Ciancio A;

A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort. in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases / Int J Infect Dis. 2024 Sep;146:107115. doi: 10.1016/j.ijid.2024.107115. Epub 2024 May 26.
2024
AOU Città della Salute di Torino

Surace L; Bassetti M; Toniutto P; Gentile I; Chemello L; Madonia S; Rosselli Del Turco E; Milella M; Chessa L; Soria A; Maida I; Foschi FG; Rocco A; Ieluzzi D; Federico A; Morsica G; Marrone A; Blanc P; Di Marco V; Laccabue D; Ferrarese A; Russo FP; Massari M; Viganò M; Fagiuoli S; Barchiesi F; Stanzione M; Coppola N; Barbaro F; et alii...

Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination. in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases / Int J Infect Dis. 2023 Apr;129:266-273. doi: 10.1016/j.ijid.2023.02.006. Epub 2023 Feb 13.
2023
AOU Città della Salute di Torino

Craxì A; Di Marco V; Lampertico P; Ferrari C; Marzano A; Fagiuoli S; Madonia S; Chemello L; Puoti M; Zignego AL; Verucchi G; Claar E; Blanc P; Coppola N; Russo FP; Ciancio A; Barbaro F; Milella M; Chessa L; Morisco F; Messina V; Cacciola I; Ferrigno L; Tosti ME; Quaranta MG; Nardi A; Brancaccio G; Coco B; Santantonio TA; et alii...

Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid. in Liver international : official journal of the International Association for the Study of the Liver / Liver Int. 2022 Nov;42(11):2453-2465. doi: 10.1111/liv.15386. Epub 2022 Aug 23.
2022
AOU Città della Salute di Torino

Scaravaglio M; Palermo A; Alvaro D; Mulinacci G; Frazzetto E; Bertino G; Palitti VP; Sacco R; Cuccorese G; Calvaruso V; Zolfino T; Scifo G; Distefano M; D'Antò M; De Gasperi E; Abenavoli L; Viganò M; Storato S; Cannavò M; Simone L; Russello M; Rosina F; Tortora A; Ponziani F; Pompili M; Pellicelli A; Muratori L; Morelli O; Chessa L; et alii...

A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort. in Hepatology (Baltimore, Md.) / Hepatology. 2022 Jul;76(1):220-232. doi: 10.1002/hep.32281. Epub 2022 Jan 19.
2022
AOU Città della Salute di Torino

Russo FP; Ciancio A; Iannone A; Chemello L; Coco B; Verucchi G; Benedetti A; Rumi MG; Coppola C; Ieluzzi D; Laccabue D; Fracanzani AL; Filomia R; Puoti M; Biliotti E; Madonia S; Andreone P; Gentile I; Masarone M; Persico M; Mazzaro C; Brancaccio G; Panetta V; Gragnani L; Quaranta MG; Kondili LA; Monti M; Barbaro F; Morisco F; et alii...